Buxton Helmsley Releases Open Letter to Directors of Daily Journal Corporation GlobeNewswire July 28, 2025 NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Buxton Helmsley USA, Inc. (“BH”), a New York City-based alternative asset manager whose brand is recognized by Bloomberg as being among the top 15% of activist investors globally (based on number of […]
Rocket Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 11, 2025 Deadline to file Lead Plaintiff Motion. GlobeNewswire July 28, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 28, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm
Consolidated Results of Operations – Three-Month Periods Ended June 30, 2025 and 2024: Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended June 30, 2025, net income was $4.5 million, or $.32 per diluted share, as compared to $5.3 million, or $.38 per diluted share, during the second quarter of
Cell Biology Researcher Mark Terasaki's $25 Million Unrestricted GiftWill Support Operations and Infrastructure The Marine Biological Laboratory today announced a $25 million gift of unrestricted support from Mark Terasaki,an MBL Whitman Scientist and Associate Professor in the University of Connecticut Health Center's Department of Cell Biology. The gift will provide $5 million annually for the
(NYSE:HIMS), NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. (“Hims & Hers Health, Inc.” or the “Company”) (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Hims & Hers Health, Inc. investors who
Hims & Hers Health, Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – HIMS GlobeNewswire July 28, 2025 NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. (“Hims & Hers Health, Inc.” or
Equifax® (NYSE: EFX) a global data, analytics and technology company, and Qlarifi, the first real-time consumer credit database purpose built for Buy Now, Pay Later lending, are partnering to conduct a joint study on the impact of BNPL reporting on credit risk assessments and fraud prevention. https://mma.prnewswire.com/media/448516/Equifax_jpg_Logo.jpg According to a recent survey, more than 50%
Broad labeling inclusive of all disease subtypes for individuals 1 month of age and older – PTC will host a conference call on Monday, July 28th at 5:00 pm ET – PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has approved SEPHIENCE™ (sepiapterin) for the treatment of children
(NasdaqGM:RCKT), NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rocket investors who were adversely affected by alleged securities fraud between February 27,
RCKT LAWSUIT ALERT: Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline GlobeNewswire July 28, 2025 NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT) of a class action securities lawsuit. CLASS DEFINITION: